Abstract
Current guidelines recommend that all neonates with Down syndrome (DS) be screened for congenital heart disease (CHD) with an echocardiogram. We sought to determine the effectiveness of a more accessible and less expensive screening strategy consisting of physical examination, electrocardiogram (ECG), and chest X-ray. The Intermountain Healthcare Enterprise Data Warehouse was used to identify infants with a positive karyotype for DS who were born between January 1, 2000, and June 30, 2012. Infants with the results of an echocardiogram, physical examination, ECG, and chest X-ray documented at age ≤6 months were included. Infants with an abnormality on physical examination, ECG, or chest X-ray were considered to have a positive screen. Echocardiography was the gold standard for calculating sensitivity, specificity, positive and negative predictive values for major CHD, defined as any heart defect that would typically require intervention during early childhood. Of 408 eligible infants, 240 (59 %) had major CHD, of whom 228 (95 %) had a positive screen. Screening missed eight infants with moderate/large patent ductus arteriosus and four infants with a moderate/large atrial septal defect. In 11 of these infants, the defect resolved spontaneously by age ≤4 months. One infant had a moderate atrial septal defect persisting at 2-year follow-up. Sensitivity and specificity of the screening for detecting CHD were 95 % (CI 92–98 %) and 41 % (CI 32–47 %); positive and negative predictive values were 69 % (CI 63–73 %) and 85 % (CI 75–92 %). Screening with physical examination, ECG, and chest X-ray is an effective method of identifying which infants with DS should have an echocardiogram. This method would have resulted in 69 (17 %) fewer echocardiograms without missing infants with major CHD.
Similar content being viewed by others
Abbreviations
- AAP:
-
American Academy of Pediatrics
- ASD:
-
Atrial septal defect
- AVSD:
-
Atrioventricular septal defect
- CHD:
-
Congenital heart disease
- DS:
-
Down syndrome
- ECG:
-
Electrocardiogram
- PDA:
-
Patent ductus arteriosus
- VSD:
-
Ventricular septal defect
References
Al-Biltagi Mohammed A (2013) Echocardiography in children with Down syndrome. World J Clin Pediatr 2(4):36–45
Bull MJ, the Committee on Genetics (2011) Health supervision for children with Down syndrome. Pediatrics 128(2):393–406
McElhinney DB, Straka M, Goldmuntz E, Zackai EH (2002) Correlation between abnormal cardiac physical examination and echocardiographic findings in neonates with Down syndrome. Am J Med Genet 113(3):238–241
Tubman TRJ, Shields MD, Craig BG, Mulholland HC, Nevin NC (1991) Congenital heart disease in Down’s syndrome: two prospective early screening study. BMJ 302:1425–1427
Bhatia S, Verma IC, Shrivastava S (1992) Congenital heart disease in Down syndrome: an echocardiographic study. Ind Pediatr 29:1113–1116
Chong ESF, Dennis J, Archer N (1998) The effectiveness of screening for congenital heart disease in a 14 year birth cohort of children with Down syndrome. Arch Dis Child 2:63 G94
Wren C, Richmond S, Donaldson L (1999) Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child 80:F49–F53
Rosenberg HC, Jung JH, Soltan HC, Li MD, Sheridan G (1994) Cardiac screening of congenital heart disease in Down syndrome. Can J Cardiol 10:675–677
Narchi H (1999) Neonatal ECG screening for congenital heart disease in Down syndrome. Ann Trop Paediatr 19(1):51–54
Shashi V, Berry MN, Covitz W (2002) A combination of physical examination and ECG detects the majority of hemodynamically significant heart defects in neonates with Down syndrome. Am J Med Genet 108(3):205–208
Mason JW, Hancock EW, Gettes LS (2007) Recommendations for the standardization and interpretation of the electrocardiogram: part II: electrocardiography diagnostic statement list: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council. J Am Coll Cardiol 49(10):1128–1135
Clapp S, Perry BL, Farooki ZQ et al (1990) Down’s syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Surg 100:115–121
Oakley JL, Soni NB, Wilson D, Sen S (2014) Effectiveness of pulse oximetry in addition to routine neonatal examination in detection of congenital heart disease in asymptomatic newborns. J Matern Fetal Neonatal Med 13:1–14
Zhao QM, Ma XJ, Ge XL et al (2014) Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet 384:747–754
Thangaratinam S, Brown K, Zamora J, Khan KS, Ewer AK (2012) Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet 379:2459–2464
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Bogarapu, S., Pinto, N.M., Etheridge, S.P. et al. Screening for Congenital Heart Disease in Infants with Down Syndrome: Is Universal Echocardiography Necessary?. Pediatr Cardiol 37, 1222–1227 (2016). https://doi.org/10.1007/s00246-016-1419-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-016-1419-2